ArticleEXCLI journal2022

Plasma lncRNA profiling identified BC200 and NEAT1 lncRNAs as potential blood-based biomarkers for late-onset Alzheimer's disease.

Majid Khodayi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.